Jessica Johnson, clinical consultant at Prime Therapeutics, shares more about common GLP-1 fraud schemes

cover image for Quarterly Drug Pipeline: October 2024 Quarterly Drug Pipeline: October 2024 Prime Therapeutics /quarterly-drug-pipeline-october-2024 Prime Therapeutics’ Quarterly Drug Pipeline...

Configure the table properties *Orphan drug status #chimeric antigen receptor T cell (CAR T) therapy intravenous (IV); Prescription Drug User Fee Act (PDUFA) Cell therapy: Aims to replace or repair...

Cover image for Quarterly Drug Pipeline: April 2025 Clinical insights and competitive intelligence on anticipated drugs in development Prime Therapeutics /quarterly-drug-pipeline-april-2025 Prime...